128 related articles for article (PubMed ID: 34547506)
1. Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development.
Kim N; Priefer R
Eur J Med Chem; 2021 Dec; 226():113856. PubMed ID: 34547506
[TBL] [Abstract][Full Text] [Related]
2. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle.
Racz B; Varadi A; Kong J; Allikmets R; Pearson PG; Johnson G; Cioffi CL; Petrukhin K
J Biol Chem; 2018 Jul; 293(29):11574-11588. PubMed ID: 29871924
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey.
Racz B; Varadi A; Pearson PG; Petrukhin K
PLoS One; 2020; 15(1):e0228291. PubMed ID: 31978148
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.
Cioffi CL; Racz B; Varadi A; Freeman EE; Conlon MP; Chen P; Zhu L; Kitchen DB; Barnes KD; Martin WH; Pearson PG; Johnson G; Blaner WS; Petrukhin K
J Med Chem; 2019 Jun; 62(11):5470-5500. PubMed ID: 31079449
[TBL] [Abstract][Full Text] [Related]
5. Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.
Cioffi CL; Racz B; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Zhu L; Kitchen DB; Barnes KD; Dobri N; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
J Med Chem; 2015 Aug; 58(15):5863-88. PubMed ID: 26181715
[TBL] [Abstract][Full Text] [Related]
6. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.
Dobri N; Qin Q; Kong J; Yamamoto K; Liu Z; Moiseyev G; Ma JX; Allikmets R; Sparrow JR; Petrukhin K
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):85-95. PubMed ID: 23211825
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.
Cioffi CL; Muthuraman P; Raja A; Varadi A; Racz B; Petrukhin K
J Med Chem; 2020 Oct; 63(19):11054-11084. PubMed ID: 32878437
[TBL] [Abstract][Full Text] [Related]
8. Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4.
Wang Y; Connors R; Fan P; Wang X; Wang Z; Liu J; Kayser F; Medina JC; Johnstone S; Xu H; Thibault S; Walker N; Conn M; Zhang Y; Liu Q; Grillo MP; Motani A; Coward P; Wang Z
Bioorg Med Chem Lett; 2014 Jul; 24(13):2885-91. PubMed ID: 24835984
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.
Cioffi CL; Dobri N; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Golden KC; Zhu L; Kitchen DB; Barnes KD; Racz B; Qin Q; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
J Med Chem; 2014 Sep; 57(18):7731-57. PubMed ID: 25210858
[TBL] [Abstract][Full Text] [Related]
10. Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands.
Coward P; Conn M; Tang J; Xiong F; Menjares A; Reagan JD
Anal Biochem; 2009 Jan; 384(2):312-20. PubMed ID: 18952041
[TBL] [Abstract][Full Text] [Related]
11. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
[TBL] [Abstract][Full Text] [Related]
12. [The perspectives of application of retinol-binding protein as a biomarker of risk of cardiovascular pathology.].
Borodkina DA; Gruzdeva OV; Belik EV; Palicheva EI; Kuzmina AA
Klin Lab Diagn; 2018; 63(2):79-84. PubMed ID: 30672670
[TBL] [Abstract][Full Text] [Related]
13. Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducers.
Nakamura S; Kamaura M; Akao Y; Nakamura N; Mizukami A; Goto A; Furuyama N; Cho N; Kasai S
Bioorg Med Chem; 2022 Jan; 54():116553. PubMed ID: 34953340
[TBL] [Abstract][Full Text] [Related]
14. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
Aeberli I; Biebinger R; Lehmann R; L'allemand D; Spinas GA; Zimmermann MB
J Clin Endocrinol Metab; 2007 Nov; 92(11):4359-65. PubMed ID: 17726085
[TBL] [Abstract][Full Text] [Related]
15. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
16. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.
Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A
Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004
[TBL] [Abstract][Full Text] [Related]
17. Impact of type 1 diabetes and insulin treatment on plasma levels and fractional synthesis rate of retinol-binding protein 4.
Jourdan M; Jaleel A; Karakelides H; Ford GC; Kahn BB; Nair KS
J Clin Endocrinol Metab; 2009 Dec; 94(12):5125-30. PubMed ID: 19850685
[TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.
Lee JW; Im JA; Lee HR; Shim JY; Youn BS; Lee DC
Obesity (Silver Spring); 2007 Sep; 15(9):2225-32. PubMed ID: 17890490
[TBL] [Abstract][Full Text] [Related]
19. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.
Norseen J; Hosooka T; Hammarstedt A; Yore MM; Kant S; Aryal P; Kiernan UA; Phillips DA; Maruyama H; Kraus BJ; Usheva A; Davis RJ; Smith U; Kahn BB
Mol Cell Biol; 2012 May; 32(10):2010-9. PubMed ID: 22431523
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.
Krzyzanowska K; Zemany L; Krugluger W; Schernthaner GH; Mittermayer F; Schnack C; Rahman R; Brix J; Kahn BB; Schernthaner G
Diabetologia; 2008 Jul; 51(7):1115-22. PubMed ID: 18437353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
